Market Overview

Hapoalim Securities Terminates Healthcare Coverage Including Bristol-Myers, Eli Lilly, Merck and Pfizer

Share:

Hapoalim Securities is terminating coverage of Bristol-Myers (NYSE: BMY), Eli Lilly (NYSE: LLY), Merck (NYSE: MRK), Pfizer (NYSE: PFE), Acorda (NASDAQ: ACOR), Alkermes (NASDAQ: ALKS), Amarin (NASDAQ: AMRN), Amylin (NASDAQ: AMLN), Arena Pharmaceuticals (NASDAQ: ARNA), Auxilium (NASDAQ: AUXL), Biospecifics (NASDAQ: BSTC), Cephalon (NASDAQ: CEPH), MannKind (NASDAQ: MNKD), Medivation (NASDAQ: MDVN), Nektar (NASDAQ: NKTR), Neurocrine Biosciences (NASDAQ: NBIX), Protalix (NYSE: PLX), Targacept (NASDAQ: TRGT) and Vanda Pharmaceuticals (NASDAQ: VNDA) due to an analyst departure.

 

Related Articles (ACOR + ALKS)

View Comments and Join the Discussion!

Posted-In: Hapoalim SecuritiesAnalyst Ratings

Latest Ratings

StockFirmActionPT
JNJCantor FitzgeraldMaintains200.0
PCTYJMP SecuritiesMaintains220.0
ADIBarclaysMaintains170.0
AMATBarclaysMaintains115.0
KMBRBC CapitalMaintains147.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com